Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 318

1.

An appraisal of the WHO hepatitis B treatment guidelines applicability to Africans.

Dusheiko G, Lemoine M.

J Hepatol. 2019 Jun;70(6):1046-1048. doi: 10.1016/j.jhep.2019.03.009. Epub 2019 Mar 28. No abstract available.

PMID:
31103095
2.

Hepatitis B virus infection in children and adolescents.

Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C, Bulterys M, Chan PL, El-Sayed MH, Giaquinto C, Jonas MM, Meyers T, Walsh N, Wirth S, Penazzato M.

Lancet Gastroenterol Hepatol. 2019 Jun;4(6):466-476. doi: 10.1016/S2468-1253(19)30042-1. Epub 2019 Apr 11. Review.

PMID:
30982722
3.

Hepatitis C virus infection in children and adolescents.

Indolfi G, Easterbrook P, Dusheiko G, El-Sayed MH, Jonas MM, Thorne C, Bulterys M, Siberry G, Walsh N, Chang MH, Meyers T, Giaquinto C, Wirth S, Chan PL, Penazzato M.

Lancet Gastroenterol Hepatol. 2019 Jun;4(6):477-487. doi: 10.1016/S2468-1253(19)30046-9. Epub 2019 Apr 11. Review.

PMID:
30982721
4.

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.

Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, Dusheiko G, Feld JJ, Gore C, Griswold MG, Hamid S, Hellard ME, Hou J, Howell J, Jia J, Kravchenko N, Lazarus JV, Lemoine M, Lesi OA, Maistat L, McMahon BJ, Razavi H, Roberts T, Simmons B, Sonderup MW, Spearman CW, Taylor BE, Thomas DL, Waked I, Ward JW, Wiktor SZ; Lancet Gastroenterology & Hepatology Commissioners.

Lancet Gastroenterol Hepatol. 2019 Feb;4(2):135-184. doi: 10.1016/S2468-1253(18)30270-X. Review. Erratum in: Lancet Gastroenterol Hepatol. 2019 May;4(5):e4.

PMID:
30647010
5.

Hepatitis B Surface Antigen Loss: Too Little, Too Late and the Challenge for the Future.

Dusheiko G, Wang B.

Gastroenterology. 2019 Feb;156(3):548-551. doi: 10.1053/j.gastro.2019.01.015. Epub 2019 Jan 11. No abstract available.

PMID:
30641057
6.

Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B.

Nguyen MH, Burak Ozbay A, Liou I, Meyer N, Gordon SC, Dusheiko G, Lim JK.

J Hepatol. 2019 Jan;70(1):24-32. doi: 10.1016/j.jhep.2018.09.021. Epub 2018 Oct 1.

7.

Current and future directions for the management of hepatitis B.

Dusheiko G.

S Afr Med J. 2018 Aug 8;108(8b):22-30. doi: 10.7196/SAMJ.2018.v108i8b.13497.

8.

Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B.

Nguyen MH, Lim JK, Burak Ozbay A, Fraysse J, Liou I, Meyer N, Dusheiko G, Gordon SC.

Hepatology. 2019 Mar;69(3):959-973. doi: 10.1002/hep.30246. Epub 2019 Feb 11.

PMID:
30175482
9.

Predicting treatment eligibility for hepatitis B in low income regions: Can treatment scores without HBV DNA testing serve the purpose?

McMahon BJ, Dusheiko G.

J Hepatol. 2018 Oct;69(4):765-766. doi: 10.1016/j.jhep.2018.06.002. Epub 2018 Jul 11. No abstract available.

PMID:
30007507
10.

Hepatitis B virus infection.

Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, Peters MG, Lai CL.

Nat Rev Dis Primers. 2018 Jun 7;4:18035. doi: 10.1038/nrdp.2018.35. Review.

PMID:
29877316
11.

Efficacy and Tolerability of Direct-Acting Antivirals for Hepatitis C in Older Adults.

Mazzarelli C, Considine A, Childs K, Carey I, Manini MA, Suddle A, Dusheiko G, Agarwal K, Cannon MD.

J Am Geriatr Soc. 2018 Jul;66(7):1339-1345. doi: 10.1111/jgs.15392. Epub 2018 May 25.

PMID:
29799112
12.

Serum NGAL can act as an early renal safety biomarker during long-term nucleos(t)ide analogue antiviral therapy in chronic hepatitis B.

Carey I, Byrne R, Childs K, Horner M, Bruce M, Wang B, Dusheiko G, Agarwal K.

J Viral Hepat. 2018 Oct;25(10):1139-1150. doi: 10.1111/jvh.12916. Epub 2018 May 11.

PMID:
29660209
13.

EASL Recommendations on Treatment of Hepatitis C 2018.

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver.

J Hepatol. 2018 Aug;69(2):461-511. doi: 10.1016/j.jhep.2018.03.026. Epub 2018 Apr 9. No abstract available.

PMID:
29650333
14.

Delineating the global challenges of hepatitis B virus infection.

Dusheiko G, Agarwal K.

Lancet Gastroenterol Hepatol. 2018 Jun;3(6):372-373. doi: 10.1016/S2468-1253(18)30093-1. Epub 2018 Mar 27. No abstract available.

PMID:
29599077
15.

Authors' reply.

Spearman CW, Sonderup MW, Dusheiko G; authors.

Lancet Gastroenterol Hepatol. 2018 Apr;3(4):224-225. doi: 10.1016/S2468-1253(18)30048-7. Epub 2018 Mar 7. No abstract available.

PMID:
29533194
16.

HBsAg and HBcrAg as predictors of HBeAg seroconversion in HBeAg-positive patients treated with nucleos(t)ide analogues.

Wang B, Carey I, Bruce M, Montague S, Dusheiko G, Agarwal K.

J Viral Hepat. 2018 Aug;25(8):886-893. doi: 10.1111/jvh.12889. Epub 2018 Apr 2.

PMID:
29532589
17.

A Shift in Thinking to Reduce Mother-to-Infant Transmission of Hepatitis B.

Dusheiko G.

N Engl J Med. 2018 Mar 8;378(10):952-953. doi: 10.1056/NEJMe1801662. No abstract available.

PMID:
29514035
18.

Eliminating hepatitis C within low-income countries - The need to cure genotypes 4, 5, 6.

Asselah T, Hassanein T, Waked I, Mansouri A, Dusheiko G, Gane E.

J Hepatol. 2018 Apr;68(4):814-826. doi: 10.1016/j.jhep.2017.11.037. Epub 2017 Dec 8. Review.

PMID:
29229584
19.

Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic review.

Fathi H, Clark A, Hill NR, Dusheiko G.

BMC Infect Dis. 2017 Nov 16;17(1):722. doi: 10.1186/s12879-017-2820-z. Review.

20.

Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030.

Sonderup MW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L, Dusheiko G, Gogela N, Lohou├Ęs-Kouacou MJ, Lam P, Lesi O, Mbaye PS, Musabeyezu E, Musau B, Ojo O, Rwegasha J, Scholz B, Shewaye AB, Tzeuton C, Kassianides C, Spearman CW; Gastroenterology and Hepatology Association of sub-Saharan Africa (GHASSA).

Lancet Gastroenterol Hepatol. 2017 Dec;2(12):910-919. doi: 10.1016/S2468-1253(17)30249-2. Review.

PMID:
29132760

Supplemental Content

Loading ...
Support Center